Krystal Biotech

Krystal Biotech touts topical gene therapy uptake, plots overseas launches
Fierce Pharma
Tue, 05/7/24 - 06:27 pm
Krystal Biotech
Vyjuvek
dystrophic epidermolysis bullosa
gene therapy
Eyedrop Version of Krystal’s Gene Therapy Vyjuvek Restores Sight in Teen
BioSpace
Thu, 02/8/24 - 11:22 am
Krystal Biotech
Vyjuvek
gene therapy
dystrophic epidermolysis bullosa
Krystal's topical gene therapy gains steam, prompting analyst group to boost sales projection
Fierce Biotech
Mon, 11/6/23 - 07:27 pm
Krystal Biotech
gene therapy
FDA approves Krystal Biotech’s KB408 for AATD treatment
Pharmaceutical Business Review
Fri, 09/22/23 - 10:10 am
Krystal Biotech
KB408
alpha-1 antitrypsin deficiency
What Will AbbVie Buy Next?
Motley Fool
Wed, 06/28/23 - 10:01 am
AbbVie
M&A
Blueprint Medicines
Krystal Biotech
Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease
Fierce Pharma
Sun, 05/21/23 - 10:48 pm
Krystal Biotech
Vyjuvek
dystrophic epidermolysis bullosa
gene therapy
FDA
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
Krystal Biotech Submits BLA for Rare Skin Disease Treatment
BioSpace
Wed, 06/22/22 - 06:59 pm
Krystal Biotech
B-VEC
FDA
dystrophic epidermolysis bullosa
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
Endpoints
Wed, 03/16/22 - 10:31 am
Krystal Biotech
dermatology
legal
PeriphaGen
gene therapy
Krystal shines in epidermolysis bullosa
EP Vantage
Tue, 11/30/21 - 10:22 am
Krystal Biotech
clinical trials
Vyjuvek
epidermolysis bullosa
Biotech companies raise cash as coronavirus updates lift stocks
BioPharma Dive
Tue, 05/19/20 - 11:24 pm
biotech
biotech stocks
COVID-19
Moderna Therapeutics
Bluebird Bio
Turning Point Therapeutics
Gossamer Bio
Krystal Biotech
Clovis Oncology
Gamida Cell
Bellerophon
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
gene therapy
drug manufacturing
Pfizer
Novartis
Bluebird Bio
PTC Therapeutics
Krystal Biotech
3 Small-Cap Biotech Stocks That Soared Last Week
Motley Fool
Mon, 07/1/19 - 10:27 am
Dova Pharmaceuticals
Doptelet
Krystal Biotech
KB103
MeiraGTx
gene therapy
AAV-RPE65
Krystal looks to Phase III as stock soars on data for gene therapy
BioCentury
Tue, 06/25/19 - 09:15 am
Krystal Biotech
gene therapy
KB103
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
CP Wire
Tue, 01/15/19 - 09:59 am
Krystal Biotech
KB103
dystrophic epidermolysis bullosa
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
Tue, 01/15/19 - 09:51 am
Krystal Biotech
KB103
dystrophic epidermolysis bullosa
Krystal Biotech Doses First Patient in Phase 1/2 trial of KB103 Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
CP Wire
Sat, 05/12/18 - 01:39 pm
Krystal Biotech
dystrophic epidermolysis bullosa
KB103
Krystal Biotech Doses First Patient in Phase 1/2 trial of KB103 Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
Fri, 05/11/18 - 09:27 am
Krystal Biotech
dystrophic epidermolysis bullosa
KB103